Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in adults and children, including community‑acquired pneumonia, skin and soft‑tissue infections, and intra‑abdominal infections.

GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company follows EU manufacturing standards and provides reliable global distribution to healthcare facilities.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections affecting the respiratory, skin, and intra‑abdominal systems.

- Community‑acquired pneumonia: effective against typical and atypical pathogens, improving clinical outcomes. - Acute bacterial sinusitis: reduces symptoms and bacterial load in sinus cavities. - Skin and soft‑tissue infections: treats infections caused by susceptible streptococci and staphylococci, including cellulitis and wound infections.

Clarithromycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Abdominal pain: cramping or discomfort. - Taste disturbance: metallic or bitter taste. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - QT interval prolongation: risk of cardiac arrhythmias. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe allergic reactions: rash, angioedema, anaphylaxis. - Clostridioides difficile colitis: severe diarrhea due to gut flora disruption.

When using clarithromycin intravenously, several precautions should be observed to ensure patient safety. - Renal impairment: monitor kidney function and adjust dosage if needed. - Hepatic impairment: assess liver enzymes and consider dose modification. - QT prolongation risk: avoid in patients with known arrhythmias or electrolyte disturbances. - Drug interactions: review concomitant medications for potential interactions. - Allergic reactions: discontinue if hypersensitivity signs appear. - Store below 25°C: keep in original container, protect from light and moisture.

Clarithromycin interacts with several medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Erythromycin and other macrolides: additive risk of QT prolongation. - Cisapride: may cause serious cardiac arrhythmias. - Theophylline: clarithromycin can increase serum theophylline levels, leading to toxicity. - Statins (lovastatin, simvastatin): increased risk of myopathy and rhabdomyolysis.

Moderate Interactions (Monitor Closely): - Warfarin: clarithromycin may enhance anticoagulant effect, requiring INR monitoring. - Carbamazepine: may reduce clarithromycin plasma concentrations, decreasing efficacy. - Oral contraceptives: possible reduction in hormonal effectiveness, advise alternative contraception.